|
Aug 12
|
RANI: Second Quarter Financial Results
|
|
Aug 7
|
Rani Therapeutics Reports Second Quarter 2025 Financial Results; Provides Corporate Update
|
|
Aug 7
|
Lilly's oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity
|
|
Aug 5
|
Chugai Pharma Taiwan Honored at the AREA 2025 for its Social Empowerment and Green Innovation
|